Alaattin ÖZEN, Cem UZAL, Sernaz UZUNOĞLU, Şemsi ALTANER, Çoşar Ruşen ALAS, Murat ÇALOĞLU, Mert SAYNAK, Yürüt Vuslat ÇALOĞLU, Burcu ÜREGEN, Zafer KOÇAK

Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi

Ekrin porokarsinom, ekrin ter bezlerinden kaynaklanan nadir bir tümördür. Alt ekstremiteler en sık görüldüğü bölgedir. Cerrahi eksizyon en iyi tedavi seçeneği gibi görünmektedir. Cerrahi sınırların temiz olması lokal nüksleri önlemek açısından önemlidir. Lenf nodu tutulumu varsa bölgesel lenf nodu diseksiyonu yapılmalıdır. Biz, gövde cildinden kaynaklanan ekrin porokarsinom tanılı 69 yaşında bir kadın olgunun klinik ve patolojik özelliklerini sunuyoruz.

Eccrine porocarcinoma: A case report and literature review

Eccrine porocarcinoma is a rare malignant sweat gland tumor. The lower extremity represents the most common tumor site for this entity. Surgical excision seems to be the best treatment choice. The surgical margins should be free of tumor, otherwise a local recurrence is most likely. Regional lymph node dissection should be performed if there is evidence of lymphadenopathy. Here, we present clinical and pathological findings of a 69 years old woman diagnosed with eccrine porocarcinoma arising from the skin of the trunk.

PDF

___

1) Whitt P, Whelchel J, Ruff T. Eccrine porocarcinoma. Ear Nose Throat J 1996;75(8):536-8.
2) Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and Paget's dermatosis. Arch Dermatol 1963;88:597 606.
3) Mishima Y, Morioka S. Oncogenic differentiation of the intraepidermal eccrine sweat duct: eccrine poroma, poroepithelioma and porocarcinoma. Dermatologica 1969;138(4):238-50.
4) Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27(2 Pt 2):306-11.
5) Ritter AM, Graham RS, Amaker B, Broaddus WC, Young HF. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. J Neurosurg 1999;90(1):138-40.
6) Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol 1983;119(2):104-14.
7) Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001;25(6):710-20.
8) Wittenberg GP, Robertson DB, Solomon AR, Washington CV. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases. Dermatol Surg 1999;25(11):911-3.
9) Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol 1996;35(5 Pt 2):860-4.
10) Arslan E, Tatar C, Aksoy A, Tutuncu N. De novo malignant eccrine poroma of the nose: a review of the midface as a location. Plast Reconstr Surg 2004;113(7):2227-9.
11) Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol 2005;6(11):877-85.
12) Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, et al. Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 2003;97(9):2285-9.
13) Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001;12(3):411-4.
14) Nabi HA, Zubeldia JM. Clinical applications of (18)FFDG in oncology. J Nucl Med Technol 2002;30(1):3-9.
15) Cho SB, Roh MR, Yun M, Yun SK, Lee MG, Chung KY. (18)F-fluorodeoxyglucose positron emission tomography detection of eccrine porocarcinoma. Br J Dermatol 2005;152(2):372-3.